Screening coverage for diabetic retinopathy using a three-field digital non-mydriatic fundus camera

Primary Care Diabetes

Volumn 2, Issue 3, 2008, Pages 141-146

  Soto Pedre, Enrique ^a   Hernaez Ortega, Maria C ^a  

^a EUROPEAN INNOVATIVE BIOMEDICINE INSTITUTE   (Spain)

Author keywords

Diabetes mellitus; Diabetic retinopathy; Prevalence; Screening; Screening coverage

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COMPUTER; DIABETIC RETINOPATHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HOSPITALIZATION; HUMAN; INSTRUMENTATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PATHOPHYSIOLOGY;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CHILD; COMPUTERS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 50949099892     PISSN: 17519918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcd.2008.04.003     Document Type: Article

References (41)

1. In: Kohner E.M., and Porta M. (Eds). Screening for Diabetic Retinopathy in Europe: A Field Guide-book (1990), World Health Organization, Geneva
2. WHO/IDF Europe. Diabetes care and research in Europe: the Saint Vincent Declaration. Diabet. Med. 7 (1990) 360
3. Klein B.E.K., Davis M.D., and Segal P. Diabetic retinopathy: assessment of severity and progression. Ophthalmology 91 (1984) 10-17
4. Brechner R.J., Cowie C.C., Howie L.J., Herman W.H., Will J.C., and Harris M.I. Ophthalmic examination among adults with diagnosed diabetes mellitus. JAMA 270 (1993) 1714-1718
5. American Diabetes Association. Screening for diabetic retinopathy. Diabetes Care 20 Suppl. 1 (1997) 28-30
6. Trento M., Bajardi M., Borgo E., et al. Perceptions of diabetic retinopathy and screening procedures among diabetic people. Diabet. Med. 19 (2002) 810-813
7. Wilson A., Baker R., Thompson J., and Grimshaw G. Coverage in screening for diabetic retinopathy according to screening provision: results from a national survey in England and Wales. Diabet. Med. 21 (2004) 271-278
8. Grupo de Trabajo de la Conferencia Nacional de Diabetes Mellitus, Documentos de los grupos de trabajo de la conferencia nacional de diabetes mellitus, Ministerio de Sanidad y Consumo, Madrid, 1992.
9. Ministerio de Sanidad y Consumo, Consenso para la atención a las personas con diabetes en España, Ministerio de Sanidad y Consumo, Madrid, 1995.
10. European Diabetes Policy Group, A Desktop Guide to Type 2 Diabetes Mellitus, International Diabetes Federation (European Region), Brussels (Belgium), 1998.
11. European Diabetes Policy Group, A Desktop Guide to Type 1 (Insulin Dependent) Diabetes Mellitus, International Diabetes Federation (European Region), Brussels (Belgium), 1998.
12. Moss S.E., Klein R., and Klein B.E.K. Factors associated with having eye examinations in persons with diabetes. Arch. Fam. Med. 4 (1995) 529-534
13. Schoenfeld E.R., Greene J.M., Wu S.Y., and Leske M.C. Patterns of adherence to diabetes vision care guidelines. Baseline findings from the Diabetic Retinopathy Awareness Program. Ophthalmology 108 (2001) 563-571
14. Soto-Pedre E., Hernaez-Ortega M.C., and Piniés J.A. Duration of diabetes and screening coverage for retinopathy among type 2 diabetes. Ophthalmic Epidemiol. 14 2 (2007) 76-79
15. World Medical Association, Declaration of Helsinki: Ethical Principals for Research Involving Human Subjects (As Amended in Tokyo), World Medical Association, Ferney-Voltaire, France, 2004.
16. Wilkinson C.P., Ferris F.L., Klein R.E., et al. Proposed international clinical diabetic retinopathy and diabetic macular oedema disease severity scales. Ophthalmology 110 (2003) 1677-1682
17. Snedecor G.W., and Cochran W.G. Statistical Methods (1989), Iowa State University Press, Ames, IO
18. Fleiss J.L. Statistical Methods for Rates and Proportions (1981), John Wiley & Sons, Inc., New York
19. StataCorp, Stata Reference Manual, Release 5.0, Stata Corporation, College Station, TX, 1997.
20. Lopez I., Diez A., Velilla S., Rueda A., Alvarez A., and Pastor J.C. Prevalence of diabetic retinopathy and eye care in a rural area of Spain. Ophthalmic Epidemiol. 9 3 (2002) 205-214
21. Arteagoitia J.M., Larrañaga M.I., Rodriguez J.L., Fernandez I., and Piniés J.A. Incidence, prevalence and coronary heart disease risk level in known type 2 diabetes: a sentinel practice network study in the Basque Country, Spain. Diabetologia 46 (2003) 899-909
22. Teruel C., Fernández-Real J.M., Ricart W., Valent R., and Vallés M. Prevalence of diabetic retinopathy in the region of Girona. Study of related factors (Spanish). Arch. Soc. Esp. Oftalmol. 80 (2005) 85-92
23. McCarty C.A., Lloyd-Smith C.W., Lee S.E., Livingston P.M., Stanislavsky Y.L., and Taylor H.R. Use of eye care services by people with diabetes: the Melbourne Visual Impairment Project. Br. J. Ophthalmol. 82 (1998) 410-414
24. Morgan C.L., Currie C.J., Stott N.C., Smithers M., Butler C.C., and Peters J.R. The prevalence of multiple diabetes-related complications. Diabet. Med. 17 (2000) 146-151
25. Wong T.Y., Klein R., Islam A., et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am. J. Ophthalmol. 141 (2006) 446-455
26. McKay R., McCarty C.A., and Taylor H.R. Diabetic retinopathy in Victoria, Australia: the visual impairment project. Br. J. Ophthalmol. 84 (2000) 865-870
27. Massin P., Aubert J.P., Erginay A., et al. Screening for diabetic retinopathy: the first telemedical approach in a primary care setting in France. Diabetes Metab. 30 (2004) 451-457
28. Malone J.I., Morrison A.D., Pavan P.R., and Cuthbertson D.D. The Diabetes Control and Complications Trial. Prevalence and significance of retinopathy in subjects with type 1 diabetes less than 5 years' duration screened for the Diabetes Control and Complications Trial. Diabetes Care 24 (2001) 522-526
29. Diabetes Control and Complications Trial (DCCT) Research Group. Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA 287 (2002) 2563-2569
30. UK Prospective Diabetes Study (UKPDS) Group. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus. Arch. Ophthalmol. 122 (2004) 1631-1640
31. Ryder R.E., Kong N., Bates A.S., Sim J., Welch J., and Kritzinger E.E. Instant electronic imaging systems are superior to Polaroid at detecting sight-threatening diabetic retinopathy. Diabet. Med. 15 3 (1998) 254-258
32. Li H.K. Telemedicine and ophtalmology. Surv. Ophthalmol. 44 (1999) 61-72
33. Liesenfeld B., Kohner E., Piehlmeier W., et al. A telemedical approach to the screening of diabetic retinopathy: digital fundus photography. Diabetes Care 23 3 (2000) 345-348
34. Hernaez-Ortega M.C., Soto-Pedre E., Vazquez J.A., Gutierrez M.A., and Asua J. Study of the efficiency of a non-mydriatic retinal camera in the diagnosis of diabetic retinopathy (Spanish). Rev. Clin. Esp. 198 (1998) 194-199
35. Scanlon P.H., Foy C., Malhotra R., and Aldington S.J. The influence of age, duration of diabetes, cataract, and pupil size on image quality in digital photographic retinal screening. Diabetes Care 28 (2005) 2448-2453
36. Von Wendt G., Heikkila K., and Summanen P. Assessment of diabetic retinopathy using two-field 60 degrees fundus photography. A comparison between red-free, black-and-white prints and colour transparencies. Acta Ophthalmol. Scand. 77 6 (1999) 638-647
37. Von Wendt G., Ronnholm P., Heikkila K., and Summanen P. A comparison between one- and two-field 60 degree fundus photography when screening for diabetic retinopathy. Acta Ophthalmol. Scand. 78 1 (2000) 14-20
38. Saari J.M., Summanen P., Kivelä T., and Saari K.M. Sensitivity and specificity of digital retinal images in grading diabetic retinopathy. Acta Ophthalmol. Scand. 82 (2004) 126-130
39. Murgatroyd H., Ellingford A., Cox A., et al. Effect of mydriasis and different field strategies on digital image screening of diabetic eye disease. Br. J. Ophthalmol. 88 (2004) 920-924
40. Greenlick M.R., Bailey J.W., Wild J., and Grover J. Characteristics of men most likely to respond to an invitation to be screened. Am. J. Public Health 69 (1979) 1011-1015
41. Rothman K.J. Modern Epidemiology (1986), Little, Brown & Company, Boston